Bristol-Myers Nears Deal In Plavix Securities Suit
Bristol-Myers Squibb Co. has reached the outline of a settlement in a securities class action that accuses the drugmaker of duping shareholders and causing a stock drop when it failed to...To view the full article, register now.
Already a subscriber? Click here to view full article